Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) EBT Margin (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed EBT Margin for 17 consecutive years, with 11.76% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1034.0% to 11.76% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 19.36% through Dec 2025, up 3670.0% year-over-year, with the annual reading at 19.36% for FY2025, 3670.0% up from the prior year.
  • EBT Margin for Q4 2025 was 11.76% at Bristol Myers Squibb, down from 25.48% in the prior quarter.
  • The five-year high for EBT Margin was 26.52% in Q1 2025, with the low at 97.06% in Q1 2024.
  • Average EBT Margin over 5 years is 10.97%, with a median of 15.9% recorded in 2021.
  • The sharpest move saw EBT Margin crashed -12149bps in 2024, then skyrocketed 12358bps in 2025.
  • Over 5 years, EBT Margin stood at 15.5% in 2021, then rose by 5bps to 16.3% in 2022, then decreased by -11bps to 14.59% in 2023, then tumbled by -90bps to 1.42% in 2024, then surged by 729bps to 11.76% in 2025.
  • According to Business Quant data, EBT Margin over the past three periods came in at 11.76%, 25.48%, and 14.45% for Q4 2025, Q3 2025, and Q2 2025 respectively.